陈峰 + 关注学者
  • 个人主页: 点击访问
  • 所属院系:公共卫生学院
  • 通讯地址:南京市江宁区龙眠大道101号
  • 认领成果数 419
  • wos被引 1,046
  • wos篇均被引 9.26

按条件检索“5”条记录

已选条件:
导出
  • 排序
  • 显示
1. Correlation between overall survival and other endpoints in metastatic breast cancer with second- or third-line chemotherapy: Literature-based analysis of 24 randomized trials PubMed SCIE SCOPUS 认领

作者:Liu, LY; Chen, F; Zhao, JS; Yu, H

作者机构:[Liu, Liya; Zhao, Jinshun] Ningbo Univ, Sch Med, Dept Prevent Med, Ningbo 315211, Zhejiang, Peoples R China.; [Chen, Feng; Yu, Hao] Nanjing Med Univ 更多

关键词:Breast cancer; Objective response rate; Progression-free survival; Subsequent chemotherapy; Time to progression

来源:BULLETIN DU CANCER,2016,Vol.103,Issue.4

WOS被引频次:1

Scopus被引频次:6

ESI学科:CLINICAL MEDICINE

JCR分区:Q4

当年影响因子:0.853

最新一期影响因子:0.853

资源类型:外文期刊论文

5. Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer PubMed SCOPUS SCIE 认领

作者:Ouyang, XN; Shi, MQ; Jie, FW; Bai, YX; Shen, P; Yu, Z; Wang, XW; Huang, C; Tao, M; Wang, ZH; Xie, CH; Wu, Q; Shu, YQ; Han, BH; Zhang, FC; Zhang, YP; Hu, CH; Ma, XT; Liang, YJ; Wang, AL; Lu, B; Shi, Y; Chen, JF; Zhuang, ZX; Wang, JJ; Huang, JJ; Wang, CH; Bai, CX; Zhou, X; Li, Q; Chen, F; Yu, H; Feng, JF

作者机构:[Ouyang, Xuenong; Jie, Fangwei] Fujian Med Univ, Fuzong Clin Coll, Nanjing Mil Command, Dept Med Oncol,Fuzhou Gen Hosp, Fuzhou, Fujian, Peoples R Chin 更多

关键词:Dulanermin; NSCLC; Objective response rate; Phase III; Progression-free survival

来源:INVESTIGATIONAL NEW DRUGS,2018,Vol.36,Issue.2

ESI学科:PHARMACOLOGY & TOXICOLOGY

最新一期影响因子:3.484

资源类型:外文期刊论文

TOP